ERN1 and cancer: However, this compound, which is based on an IRE1 ligand that binds to the RNase domain linked to a ligand that recruits the ubiquitin ligase CRBN, afforded only partial degradation of IRE1 in HEK293T cells, while its ability to inhibit IRE1-dependent cancer-cell growth was not investigated22,23.